Literature DB >> 27042833

Evaluation of EPI-X4 as a urinary peptide biomarker for diagnosis and prognosis of late acute GvHD.

J A Müller1, O Zirafi1, N R Roan2,3, S J Lee4, J Münch1,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27042833      PMCID： PMC4972659          DOI： 10.1038/bmt.2016.65

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

Review 2.  Discovery and validation of graft-versus-host disease biomarkers.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

3.  Discovery and characterization of an endogenous CXCR4 antagonist.

Authors:  Onofrio Zirafi; Kyeong-Ae Kim; Ludger Ständker; Katharina B Mohr; Daniel Sauter; Anke Heigele; Silvia F Kluge; Eliza Wiercinska; Doreen Chudziak; Rudolf Richter; Barbara Moepps; Peter Gierschik; Virag Vas; Hartmut Geiger; Markus Lamla; Tanja Weil; Timo Burster; Andreas Zgraja; Francois Daubeuf; Nelly Frossard; Muriel Hachet-Haas; Fabian Heunisch; Christoph Reichetzeder; Jean-Luc Galzi; Javier Pérez-Castells; Angeles Canales-Mayordomo; Jesus Jiménez-Barbero; Guillermo Giménez-Gallego; Marion Schneider; James Shorter; Amalio Telenti; Berthold Hocher; Wolf-Georg Forssmann; Halvard Bonig; Frank Kirchhoff; Jan Münch
Journal:  Cell Rep       Date:  2015-04-23       Impact factor: 9.423

4.  Elafin is a biomarker of graft-versus-host disease of the skin.

Authors:  Sophie Paczesny; Thomas M Braun; John E Levine; Jason Hogan; Jeffrey Crawford; Bryan Coffing; Stephen Olsen; Sung W Choi; Hong Wang; Vitor Faca; Sharon Pitteri; Qing Zhang; Alice Chin; Carrie Kitko; Shin Mineishi; Gregory Yanik; Edward Peres; David Hanauer; Ying Wang; Pavan Reddy; Samir Hanash; James L M Ferrara
Journal:  Sci Transl Med       Date:  2010-01-06       Impact factor: 17.956

5.  A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

Authors:  John E Levine; Thomas M Braun; Andrew C Harris; Ernst Holler; Austin Taylor; Holly Miller; John Magenau; Daniel J Weisdorf; Vincent T Ho; Javier Bolaños-Meade; Amin M Alousi; James L M Ferrara
Journal:  Lancet Haematol       Date:  2014-12-23       Impact factor: 18.959

6.  High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.

Authors:  Doris M Ponce; Patrick Hilden; Christen Mumaw; Sean M Devlin; Marissa Lubin; Sergio Giralt; Jenna D Goldberg; Alan Hanash; Katharine Hsu; Robert Jenq; Miguel-Angel Perales; Craig Sauter; Marcel R M van den Brink; James W Young; Renier Brentjens; Nancy A Kernan; Susan E Prockop; Richard J O'Reilly; Andromachi Scaradavou; Sophie Paczesny; Juliet N Barker
Journal:  Blood       Date:  2014-11-06       Impact factor: 22.113

Review 7.  Next generation treatment of acute graft-versus-host disease.

Authors:  J Magenau; P Reddy
Journal:  Leukemia       Date:  2014-06-18       Impact factor: 11.528

8.  Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation.

Authors:  Thorsten Kaiser; Haytham Kamal; Andreas Rank; Hans-Jochem Kolb; Ernst Holler; Arnold Ganser; Bernd Hertenstein; Harald Mischak; Eva Maria Weissinger
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

Review 9.  Biomarkers for acute GVHD: can we predict the unpredictable?

Authors:  Y-B Chen; C S Cutler
Journal:  Bone Marrow Transplant       Date:  2012-08-06       Impact factor: 5.483

10.  Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Mukta Arora; Corey S Cutler; Madan H Jagasia; Joseph Pidala; Xiaoyu Chai; Paul J Martin; Mary E D Flowers; Yoshihiro Inamoto; George L Chen; William A Wood; Nandita Khera; Jeanne Palmer; Hien Duong; Sally Arai; Sebastian Mayer; Iskra Pusic; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2015-11-02       Impact factor: 5.742
View more
  3 in total

1.  Endogenous Peptide Inhibitors of HIV Entry.

Authors:  Mirja Harms; Manuel Hayn; Fabian Zech; Frank Kirchhoff; Jan Münch
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations.

Authors:  Andrea Gilg; Mirja Harms; Lia-Raluca Olari; Ann-Kathrin Urbanowitz; Halvard Bonig; Jan Münch
Journal:  J Transl Med       Date:  2021-05-03       Impact factor: 8.440

3.  Microtiter plate-based antibody-competition assay to determine binding affinities and plasma/blood stability of CXCR4 ligands.

Authors:  Mirja Harms; Andrea Gilg; Ludger Ständker; Ambros J Beer; Benjamin Mayer; Volker Rasche; Christian W Gruber; Jan Münch
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.